BioCardia, Inc. (BCDA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q1 '10: 0 Q2 '10: 0 Q3 '10: 0 Q4 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: 0 Q4 '11: 12K Q1 '12: 11K Q2 '12: 17K Q3 '12: 19K Q1 '16: 178K Q2 '16: 144K Q3 '16: 117K Q4 '16: 137K Q1 '17: 137K Q2 '17: 112K Q3 '17: 130K Q4 '17: 100K Q1 '18: 199K Q2 '18: 239K Q3 '18: 84K Q4 '18: 103K Q1 '19: 216K Q2 '19: 86K Q3 '19: 194K Q4 '19: 215K Q1 '20: 38K Q2 '20: 27K Q3 '20: 34K Q4 '20: 46K Q1 '21: 46K Q2 '21: 69K Q3 '21: 821K Q4 '21: 79K Q1 '22: 60K Q2 '22: 974K Q3 '22: 212K Q4 '22: 106K Q1 '23: 64K Q2 '23: 43K Q3 '23: 357K Q4 '23: 13K Q1 '24: 55K Q2 '24: 3K Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q2 '10 Q1 '12 Q1 '17 Q4 '18 Q3 '20 Q2 '22 Q1 '24 Q4 '25

Gross Profit Quarterly

0 25K 50K 75K Q1 '10: 0 Q2 '10: 0 Q3 '10: 0 Q4 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: 0 Q4 '11: 12K Q1 '12: 11K Q2 '12: 17K Q3 '12: 19K Q4 '12: 15K Q1 '13: 38K Q2 '13: 69K Q2 '10 Q4 '10 Q2 '11 Q4 '11 Q2 '12 Q4 '12 Q2 '13

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '10: -191K Q2 '10: -139K Q3 '10: -107K Q4 '10: -146K Q1 '11: -101K Q2 '11: -249K Q3 '11: -110K Q4 '11: -158K Q1 '12: -58K Q2 '12: -132K Q3 '12: -83K Q4 '12: -66K Q1 '13: -26K Q2 '13: 6K Q3 '13: 26K Q4 '13: 3K Q1 '14: 63K Q2 '14: 65K Q3 '14: 42K Q4 '14: 61K Q1 '15: 75K Q2 '15: 72K Q3 '15: 83K Q4 '15: -5.6M Q1 '16: -1.1M Q2 '16: -1.4M Q3 '16: -1.7M Q4 '16: -3.5M Q1 '17: -2.9M Q2 '17: -3M Q3 '17: -3M Q4 '17: -3.5M Q1 '18: -3.6M Q2 '18: -3.3M Q3 '18: -3.6M Q4 '18: -3.7M Q1 '19: -3.7M Q2 '19: -3.8M Q3 '19: -3.2M Q4 '19: -3.5M Q1 '20: -4.6M Q2 '20: -3.6M Q3 '20: -3.8M Q4 '20: -3.5M Q1 '21: -3M Q2 '21: -3.5M Q3 '21: -2.7M Q4 '21: -3.5M Q1 '22: -3.3M Q2 '22: -2.5M Q3 '22: -3.1M Q4 '22: -3M Q1 '23: -3.5M Q2 '23: -3.5M Q3 '23: -2.6M Q4 '23: -2.1M Q1 '24: -2.3M Q2 '24: -1.6M Q3 '24: -1.8M Q4 '24: -2.3M Q1 '25: -2.7M Q2 '25: -2.1M Q3 '25: -1.5M Q4 '25: -2M Q1 '26: -2.3M Q2 '26: -1.6M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q1 '10: -1.5M Q2 '10: -1.5M Q3 '10: -8.1M Q4 '10: -459K Q1 '11: -321K Q2 '11: 10.8M Q3 '11: -561K Q4 '11: -292K Q1 '12: -55K Q2 '12: -129K Q3 '12: 451K Q4 '12: 38K Q1 '13: -25K Q2 '13: 9K Q3 '13: 30K Q4 '13: 5K Q1 '14: 64K Q2 '14: 66K Q3 '14: 43K Q4 '14: 61K Q1 '15: 76K Q2 '15: 73K Q3 '15: 83K Q4 '15: -6.9M Q1 '16: -1.5M Q2 '16: -2M Q3 '16: -3.3M Q4 '16: -3.6M Q1 '17: -2.9M Q2 '17: -2.9M Q3 '17: -3M Q4 '17: -3.5M Q1 '18: -3.6M Q2 '18: -3.2M Q3 '18: -3.5M Q4 '18: -3.6M Q1 '19: -3.7M Q2 '19: -3.8M Q3 '19: -3.8M Q4 '19: -3.5M Q1 '20: -4.6M Q2 '20: -3.6M Q3 '20: -3.8M Q4 '20: -3M Q1 '21: -3M Q2 '21: -3.5M Q3 '21: -2.7M Q4 '21: -3.5M Q1 '22: -3.3M Q2 '22: -2.5M Q3 '22: -3.1M Q4 '22: -3M Q1 '23: -3.5M Q2 '23: -3.4M Q3 '23: -2.6M Q4 '23: -2.1M Q1 '24: -2.3M Q2 '24: -1.6M Q3 '24: -1.7M Q4 '24: -2.3M Q1 '25: -2.7M Q2 '25: -2M Q3 '25: -1.5M Q4 '25: -2M Q1 '26: -2.3M Q2 '26: -1.6M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 70K 140K 210K Q1 '10: 0 Q2 '10: 0 Q3 '10: 0 Q4 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: 0 Q4 '11: 0 Q1 '12: 0 Q2 '12: 0 Q3 '12: 0 Q4 '12: 0 Q1 '13: 0 Q2 '13: 0 Q1 '17: 175K Q2 '17: 203K Q3 '17: 147K Q4 '17: 165K Q1 '18: 157K Q2 '18: 135K Q3 '18: 109K Q4 '18: 116K Q1 '19: 106K Q2 '19: 191K Q3 '19: 24K Q4 '19: 37K Q1 '20: 4K Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q4 '10 Q1 '12 Q2 '13 Q1 '18 Q2 '19 Q3 '20 Q4 '21

Operating Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '10: -1.1M Q4 '10: -570K Q1 '11: -558K Q2 '11: -1.8M Q3 '11: 87K Q4 '11: -809K Q1 '12: -26K Q2 '12: -668K Q3 '12: -61K Q1 '13: -14K Q2 '13: 15K Q3 '13: -6K Q4 '13: 32K Q1 '14: 27K Q2 '14: 79K Q3 '14: 55K Q4 '14: 53K Q1 '15: 89K Q2 '15: 90K Q3 '15: 38K Q4 '15: -7.2M Q1 '16: -748K Q2 '16: -1.1M Q3 '16: 7.5M Q4 '16: -2.5M Q1 '17: -2.3M Q2 '17: -2.1M Q3 '17: -1.8M Q4 '17: -2.5M Q1 '18: -3M Q2 '18: -2.8M Q3 '18: -2M Q4 '18: -3.2M Q1 '19: -2.5M Q2 '19: -2.3M Q3 '19: -1.5M Q4 '19: -3.3M Q1 '20: -3M Q2 '20: -2.3M Q3 '20: -3.6M Q4 '20: -3.4M Q1 '21: -1.9M Q2 '21: -2.9M Q3 '21: -2.6M Q4 '21: -3M Q1 '22: -2.9M Q2 '22: -2.6M Q3 '22: -2M Q4 '22: -3M Q1 '23: -2.6M Q2 '23: -3.2M Q3 '23: -2.4M Q4 '23: -1.9M Q1 '24: -1.5M Q2 '24: -1.3M Q3 '24: -2.6M Q4 '24: -2.4M Q1 '25: -1.6M Q2 '25: -1.6M Q3 '25: -1.7M Q4 '25: -2.5M Q1 '26: -1.7M Q2 '26: -1.7M Q1 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '10: -1.5M Q4 '10: -571K Q1 '11: -610K Q2 '11: -1.9M Q3 '11: 87K Q4 '11: -809K Q1 '12: -26K Q2 '12: -668K Q3 '12: -61K Q1 '17: -2.3M Q2 '17: -2.1M Q3 '17: -1.8M Q4 '17: -2.6M Q1 '18: -3M Q2 '18: -2.8M Q3 '18: -2M Q4 '18: -3.3M Q1 '19: -2.5M Q2 '19: -2.3M Q3 '19: -1.5M Q4 '19: -3.3M Q1 '20: -3M Q2 '20: -2.3M Q3 '20: -3.6M Q4 '20: -3.4M Q1 '21: -1.9M Q2 '21: -2.9M Q3 '21: -2.7M Q4 '21: -3M Q1 '22: -2.9M Q2 '22: -2.7M Q3 '22: -2M Q4 '22: -3M Q1 '23: -2.6M Q2 '23: -3.2M Q3 '23: -2.4M Q4 '23: -1.9M Q1 '24: -1.5M Q2 '24: -1.3M Q3 '24: -2.6M Q4 '24: -2.4M Q1 '25: -1.6M Q2 '25: -1.6M Q3 '25: -1.7M Q4 '25: -2.5M Q1 '26: -1.7M Q2 '26: -1.7M Q3 '11 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q2 '10: 230.3M Q3 '10: 230.3M Q1 '11: 230.3M Q2 '11: 230.3M Q3 '11: 230.3M Q1 '12: 230.3M Q2 '12: 230.3M Q3 '12: 230.3M Q1 '13: 230.3M Q2 '13: 230.3M Q3 '13: 230.3M Q1 '14: 230.3M Q2 '14: 230.3M Q3 '14: 230.3M Q1 '15: 230.3M Q2 '15: 230.3M Q3 '15: 230.3M Q1 '16: 230.3M Q2 '16: 230.3M Q3 '16: 230.5M Q1 '21: 16.6M Q2 '21: 17M Q3 '21: 17.1M Q1 '22: 17.1M Q2 '22: 17.7M Q3 '22: 17.8M Q1 '23: 20.2M Q2 '23: 1.4M Q3 '23: 1.4M Q1 '24: 1.7M Q2 '24: 1.9M Q3 '24: 2.8M Q1 '25: 4.6M Q2 '25: 5.1M Q3 '25: 6.3M Q1 '26: 10.8M Q2 '26: 12.1M Q3 '10 Q2 '12 Q1 '14 Q3 '15 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '10: -0.05 Q1 '11: -0.05 Q2 '11: 0.01 Q3 '12: -0.06 Q4 '12: 0.00 Q1 '13: 0.00 Q2 '13: 0.00 Q3 '13: 0.00 Q4 '13: 0.00 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: 0.00 Q4 '14: 0.00 Q1 '15: 0.00 Q2 '15: 0.00 Q3 '15: 0.00 Q4 '15: -4.29 Q4 '17: -2.91 Q1 '18: -2.92 Q2 '18: -3.60 Q3 '18: -4.35 Q4 '18: -2.53 Q1 '19: -3.30 Q2 '19: -3.31 Q3 '19: -3.11 Q4 '19: -2.74 Q1 '20: -2.55 Q2 '20: -2.24 Q3 '20: -1.91 Q4 '20: -1.58 Q1 '21: -1.09 Q2 '21: -0.83 Q3 '21: -0.69 Q4 '21: -0.75 Q1 '22: -0.76 Q2 '22: -0.70 Q3 '22: -0.71 Q4 '22: -0.66 Q1 '23: -0.64 Q2 '23: -3.02 Q3 '23: -4.64 Q4 '23: -5.80 Q1 '24: -6.98 Q2 '24: -5.34 Q3 '24: -4.16 Q4 '24: -3.09 Q1 '25: -2.33 Q2 '25: -1.85 Q3 '25: -1.48 Q4 '25: -1.29 Q1 '26: -0.91 Q2 '26: -0.64 Q2 '11 Q1 '14 Q4 '15 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.